Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Barinthus Biotherapeutics ( (BRNS) ) has issued an announcement.
Barinthus Biotherapeutics plc has announced the promotion of Graham Griffiths from Chief Business Officer to Chief Operating Officer, effective September 1, 2024. Griffiths, who joined the company in 2017 and has a rich background in biotech leadership, will see his salary increase to £336,144 with this new role. The promotion is based solely on merit, with no family or insider connections influencing the decision.
For detailed information about BRNS stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “More Hopeful than Real”: Is a Bidding War Brewing for Warner Bros. Discovery Stock (NASDAQ:WBD)?
- “Didn’t Develop the Way Automakers Thought.” Ford Notches Up, Reconsidering the EV Market
- “Our Focus is Increasingly…on Inference”: Intel Stock (NASDAQ:INTC) Jumps With Crescent Island Testing Next Year